pills

Medical Devices DECODED

Previous edition: 09 May 2024
Share article

Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now

Register Now

Now Software Inc has extended it time and contact management software, Now Up-to-date, to run under Windows. The Portland, Oregon-based company said the move would expand its corporate customer base. Now Software sells mainly to large corporates that use a mixed environment of Macintosh and Windows personal computers and therefore need software than will run under both operating systems. Now Up-to-Date includes QuickAccess Manager, a permanent on-screen toolbar that gives users access to schedules, name and numbers, and additional diary dates that when entered in the QuickPad automatically appear under the appropriate date. The company said that its main rival was Microsoft Corp's Schedule Plus, which is given away with Microsoft Office. Now said that it had the edge over Schedule Plus because Now Up-to-date ran under more operating systems. It claims to be compatible with Macintosh, Windows 3.1 and Windows95. Now said it is currently working on expanding its software so it can be accessed by remote users with Personal Digital Assistants and pagers. It is also looking at making the software available on corporate Web servers so that companies can offer this information as part of their Web sites. The single-user version costs #100 and will be available this week. The workgroup edition for five users will costs #475, a 10-user version will costs #875 and a 50-user version will cost #3,900. Workgroup editions will be shipping next month.

Latest news

15th Annual Outsourcing in Clinical Trials East Coast 2024

The upcoming Outsourcing in Clinical Trials Europe 2024 conference will explore advancements in the clinical trial industry.

FDA issues warning on Getinge device amid quality concerns

Following a series of voluntary recalls, the FDA has urged healthcare providers to avoid Getinge’s intra-aortic balloon pumps over safety concerns.

4C Medical's AltaValve gains dual breakthrough designations from FDA

The device has received the designation for treating mitral regurgitation and mitral annular calcification.

UK report warns that economic instability is threatening life sciences sector

The report published by the Medicines Discovery Catapult warns that a mix of economic uncertainty and lack of facility access is pushing investors away from Britain’s healthcare SMEs.

Biosense introduces CARTO 3 System Version 8

The latest version features new modules, including the CARTO ELEVATE Module and CARTOSOUND FAM Module.

Qiagen and FBI partner on DNA quant digital PCR assays

The collaboration aims to develop a first-of-its-kind digital PCR assay capable of detecting and quantifying minimal amounts of DNA with high accuracy.

Vivalink introduces new solution for MCT and Holter monitoring

The new technology combines RPM technologies with advanced arrhythmia detection algorithms.

iHealth's COVID-19/Flu rapid test secures FDA EUA

Intended for over-the-counter use, the 3-in-1 test is intended for detecting Covid-19 and influenzas A and B.

Biotechs must prioritise ethics to deter GenAI “bad actors”

At the London Biotechnology Show, Microsoft’s senior director of life sciences discussed the ethical use of GenAI.

Leica Microsystems adds Viventis Microscopy to portfolio

The addition of Viventis adds light sheet technology to Leica’s line of research microscopes.

Explore Company Profiles  

Deep dive into the leading companies across your sector, uncover the drivers behind their success, and get instant access to financial data & analysis. 

Start Your Search 

In our previous edition

Newsletters in other sectors

Aerospace, Defence & Security

UAE enhances defence arsenal with HARM missile upgrade
09 May 2024

Explore our market-leading Intelligence Centers

Still looking?

Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries

Explorer

Access more premium companies when you subscribe to Explorer